No coin nor oath required. For personal study only.
for the nine months of 2006 was $138.4 M, or $1.43/ share. Net sales for nine months of 2007 were $1.74 bn ($1.78 bn in nine months of 2006). Catalysts recorded net sales for 3Q 2007 of $216.4 M, a nominal decrease versus 3Q 2006, due primarily to lower volumes in HPC refinery catalysts, partially offset by improved pricing in FCC refinery catalysts and polyolefin catalysts. R&D expenses increased $3.9 M to $15.422 M for 3Q 2007 ($11.549 M in 3Q 2006).
๐ SIMILAR VOLUMES
are working together in the US on the creation of so-called biorefineries for the production of industrial chemicals, feedstocks, and consumer products from vegetable oils. The biorefinery concept is based on proprietary olefin metathesis technology from Materia in which catalyst performance has now
Novozymes has signed a loan agreement with NIB whereby it will receive โฌ30 M to fund research and development in the area of biofuel production from waste and crop residues. This replaces an earlier loan from NIB. A new generation of enzymes will be used to produce biofuels from the stems, leaves, a